HealthInvest Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	$2.77M	Sell	32,381 -44,403	-58%	-$3.79M	5.84%	8
2017 Q3	$6.52M	Sell	76,784 -13,305	-15%	-$1.13M	7.62%	6
2017 Q2	$6.82M	Buy	+90,089	New	+$6.82M	8.51%	8